Clinical Trial Update: Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial comparing STA363 to placebo in chronic discogenic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discogenic Low Back Pain
• Discogenic Pain
• Low Back Pain

Drugs mentioned

• STA363

Snippet

Sponsor: Stayble Therapeutics | Conditions: Discogenic Pain | Phase 2 | Status: COMPLETED